Related Experiment Video
Updated: Aug 12, 2025

Imaging Analysis of Neuron to Glia Interaction in Microfluidic Culture Platform MCP-based Neuronal Axon and Glia Co-culture System
Published on: October 14, 2012
Analysis of Aβ-induced neurotoxicity and microglial responses in simple two- and three-dimensional human iPSC-derived
Mayuko Takata1, Kaneyasu Nishimura1, Koki Harada1
1Division of Integrated Pharmaceutical Sciences, Kyoto Pharmaceutical University, Misasagi, Yamashina-ku, Kyoto 607-8414, Japan.
Abstract:
The extracellular accumulation of amyloid-β (Aβ) in plaques and associated neurodegeneration are the pathological hallmarks of Alzheimer's disease (AD). These plaques are surrounded by microglia-the resident tissue macrophages of the brain parenchyma that originate from primitive macrophages from the embryonic yolk sac. Microglia, including a unique subpopulation called "disease-associated microglia" (DAM), are strongly implicated in AD pathology; however, their exact function and physiology remain largely unknown. Notably, simple cell and tissue culture systems that adequately recreate the brain microenvironment and can simulate critical aspects of AD pathology could fundamentally contribute to elucidating microglial function in disease development and progression. Thus, we added human-induced pluripotent stem cell (hiPSC)-induced primitive macrophages (hiMacs) to hiPSC-induced cortical neurons (cell model) and cortical organoids (tissue model). The treatment of these culture systems with the O-acyl isopeptide of Aβ1-42, which reverts to natural extracellular Aβ1-42 at neutral pH and starts self-aggregation, caused the degeneration of hiPSC-induced cortical neurons in 2D culture and within cortical organoid cultures. Notably, the hiMacs phagocytosed extracellular Aβ and exhibited a DAM-like phenotype. In both cell and tissue organoid culture systems, neurodegeneration was attenuated by the addition of hiMacs. Moreover, in cortical organoids, Aβ plaques formed more circular and fewer hotspot-like morphological structures in the vicinity of hiMacs. These findings demonstrate the utility of simple hiPSC-induced cortical cell and tissue culture systems supplemented with hiMacs for elucidating critical aspects of AD pathology, such as microglial function and physiology. Adopting such systems in routine research practice may lead to the development of novel therapeutic strategies for AD.
Insights
Human-induced primitive macrophages (hiMacs) protect against Alzheimer's disease (AD) pathology in cell and organoid models. These hiMacs reduce neurodegeneration and alter amyloid-β plaque formation, offering new therapeutic avenues for AD.
Area of Science:
- Neuroscience
- Stem Cell Biology
- Alzheimer's Disease Research
Background:
- Alzheimer's disease (AD) is characterized by amyloid-β (Aβ) plaques and neurodegeneration.
- Microglia, brain-resident macrophages, are implicated in AD, but their precise role is unclear.
- Existing cell and tissue culture models often fail to fully replicate the brain microenvironment for studying microglial function in AD.
Purpose of the Study:
- To investigate the function and physiology of microglia in Alzheimer's disease using novel human-induced pluripotent stem cell (hiPSC)-derived models.
- To evaluate the protective effects of hiPSC-induced primitive macrophages (hiMacs) on neuronal degeneration and Aβ pathology in vitro.
Main Methods:
- Developed 2D cortical cell and 3D cortical organoid models using hiPSC-derived neurons and hiPSC-derived primitive macrophages (hiMacs).
- Treated these models with aggregated Aβ₁-42 to induce AD-like pathology.
- Analyzed hiMacs' phagocytosis of Aβ, their phenotypic changes (DAM-like), and their impact on neurodegeneration and plaque morphology.
Main Results:
- Aβ₁-42 induced cortical neuron degeneration in both 2D and organoid cultures.
- hiMacs effectively phagocytosed extracellular Aβ and adopted a disease-associated microglia (DAM)-like phenotype.
- The presence of hiMacs attenuated neurodegeneration and promoted more circular, less clustered Aβ plaque formation in organoid models.
Conclusions:
- hiPSC-derived cell and organoid systems supplemented with hiMacs are valuable tools for studying AD pathology and microglial roles.
- hiMacs demonstrate a protective effect against Aβ-induced neurodegeneration.
- These findings support the development of hiPSC-based models for discovering novel therapeutic strategies for Alzheimer's disease.

